Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 163
Diabetes and the COVID-19 pandemic
Kamlesh Khunti, Jonathan Valabhji, Shivani Misra
Diabetologia (2022) Vol. 66, Iss. 2, pp. 255-266
Open Access | Times Cited: 76
Safety and efficacy of COVID‐19 vaccines: A systematic review and meta‐analysis of controlled and randomized clinical trials
Jayesh Beladiya, Anup Kumar, Yogesh Vasava, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 43
Tinospora cordifolia (Giloy): An insight on the multifarious pharmacological paradigms of a most promising medicinal ayurvedic herb
Abhishek Gupta, Priyanka Gupta, G. K. Bajpai
Heliyon (2024) Vol. 10, Iss. 4, pp. e26125-e26125
Open Access | Times Cited: 13
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents
Tommaso Felicetti, Chiara Sarnari, Roberta Gaito, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 8
An Educational Mobile Health Application for Pulmonary Rehabilitation in Patients With Mild to Moderate COVID-19 Pneumonia
Havva Talay Çalış, İsa Cüce, Elif Polat, et al.
Advances in medical education, research, and ethics (AMERE) book series (2023), pp. 220-242
Closed Access | Times Cited: 22
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV
Andrea Ricci, Giovanni N. Roviello
Life (2023) Vol. 13, Iss. 2, pp. 402-402
Open Access | Times Cited: 19
Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions
Zaigham Abbas Rizvi, Prabhakar Babele, Upasna Madan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Potential Pharmacological Applications of Nigella Seeds with a Focus on Nigella sativa and Its Constituents against Chronic Inflammatory Diseases: Progress and Future Opportunities
Shadma Wahab, Abdulrhman Alsayari
Plants (2023) Vol. 12, Iss. 22, pp. 3829-3829
Open Access | Times Cited: 17
A newly developed and validated environmentally friendly RP-HPLC stability indicating method for the COVID-19 antiviral Molnupiravir: Application to degradation kinetics structure suggestion using LC-MS and the effect on viable cells of the major degradation products
Hebatallah A. Wagdy
Microchemical Journal (2024) Vol. 199, pp. 109980-109980
Closed Access | Times Cited: 6
Global landscape of COVID-19 research: a visualization analysis of randomized clinical trials
Sa’ed H. Zyoud
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Identification of new pharmacophore against SARS-CoV-2 spike protein by multi-fold computational and biochemical techniques
Atta Ullah, Saeed Ullah, Sobia Ahsan Halim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects
Min Meng, Weiwei Zhang, Shuangfeng Chen, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 2, pp. 70-88
Open Access | Times Cited: 6
Impact of COVID-19 on antibiotic usage in primary care: a retrospective analysis
Anna Romaszko–Wojtowicz, Kornelia Tokarczyk-Malesa, Anna Doboszyńska, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19
Diana Badenes Bonet, Oswaldo Antonio Caguana Vélez, Xavier Durán, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 4158-4158
Open Access | Times Cited: 16
Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy
Razia Batool, Maria Soler, Francesca Colavita, et al.
Biosensors and Bioelectronics (2023) Vol. 226, pp. 115137-115137
Open Access | Times Cited: 14
miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome
Milena Janković, Dejan Nikolić, Ivana Novaković, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 14
Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: The study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses
Chiranjib Chakraborty, Manojit Bhattacharya, Abdulrahman Alshammari, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 12, pp. 1961-1970
Open Access | Times Cited: 14
Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain
Lavinia M. Sherrill, Elva E. Joya, AnnMarie Walker, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 67, pp. 116788-116788
Open Access | Times Cited: 20
Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: Pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies
Mohsen Yazdani, Ameneh Jafari, Soodeh Mahdian, et al.
Journal of Molecular Liquids (2023) Vol. 375, pp. 121345-121345
Open Access | Times Cited: 12
The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19
Aline Almeida-Oliveira, Diana Freire, A. Andrade, et al.
Journal of Pharmaceutical Innovation (2023) Vol. 18, Iss. 3, pp. 1194-1212
Open Access | Times Cited: 12
Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
Alberto Papi, Renee D. Stapleton, Paul Shore, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 159-170
Open Access | Times Cited: 12
From Archipelago to Pandemic Battleground: Unveiling Indonesia’s COVID-19 Crisis
Biyan Nathanael Harapan, Triswan Harapan, Lenny Theodora, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 591-603
Open Access | Times Cited: 11
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín‐Quirós, et al.
Cytotherapy (2023) Vol. 26, Iss. 1, pp. 25-35
Closed Access | Times Cited: 11
Isolation and Preliminary Characterization of a Novel scFv against SARS-CoV-2 : an Experimental and Computational Analysis
Samaneh Jahandar-Lashaki, Safar Farajnia, Effat Alizadeh, et al.
Avicenna Journal of Medical Biotechnology (2025)
Closed Access
Page 1 - Next Page

Scroll to top